BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8800734)

  • 1. Corticosteroid weaning late after heart transplantation: relation to HLA-DR mismatching and long-term metabolic benefits.
    Kobashigawa JA; Stevenson LW; Brownfield ED; Gleeson MP; Moriguchi JD; Kawata N; Minkley R; Drinkwater DC; Laks H
    J Heart Lung Transplant; 1995; 14(5):963-7. PubMed ID: 8800734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA mismatching and outcome in heart, heart-lung, and single lung transplantation.
    Keogh A; Kaan A; Doran T; Macdonald P; Bryant D; Spratt P
    J Heart Lung Transplant; 1995; 14(3):444-51. PubMed ID: 7654729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved long-term survival after heart transplantation predicted by successful early withdrawal from maintenance corticosteroid therapy.
    Taylor DO; Bristow MR; O'Connell JB; Price GD; Hammond EH; Doty DB; Karwande SV; Gay WA; Jones KW; Lappé D; Renlund DG
    J Heart Lung Transplant; 1996 Oct; 15(10):1039-46. PubMed ID: 8913922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DR incompatibility predicts heart transplant rejection independent of immunosuppressive prophylaxis.
    Costanzo-Nordin MR; Fisher SG; O'Sullivan EJ; Johnson M; Heroux A; Kao W; Mullen GM; Radvany R; Robinson J
    J Heart Lung Transplant; 1993; 12(5):779-89. PubMed ID: 8241215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful withdrawal of prednisone after adult liver transplantation for autoimmune hepatitis.
    Trouillot TE; Shrestha R; Kam I; Wachs M; Everson GT
    Liver Transpl Surg; 1999 Sep; 5(5):375-80. PubMed ID: 10477838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-2 receptor blockade in cardiac transplantation: influence of HLA-DR locus incompatibility on treatment efficacy.
    Lietz K; John R; Beniaminovitz A; Burke EM; Suciu-Foca N; Mancini DM; Edwards NM; Itescu S
    Transplantation; 2003 Mar; 75(6):781-7. PubMed ID: 12660501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-year survival rates for all consecutive heart-only and lung-only transplants performed in Eurotransplant, 1997-1999.
    Smits JM; Vanhaecke J; Haverich A; de Vries E; Smith M; Rutgrink E; Ramsoebhag A; Hop A; Persijn G; Laufer G
    Clin Transpl; 2003; ():89-100. PubMed ID: 15387100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial success of steroid weaning late after heart transplantation.
    Kobashigawa JA; Stevenson LW; Brownfield ED; Moriguchi JD; Kawata N; Fandrich R; Drinkwater DC; Laks H
    J Heart Lung Transplant; 1992; 11(2 Pt 2):428-30. PubMed ID: 1571341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rejection in heart transplantation strongly correlates with HLA-DR antigen mismatch.
    Sheldon S; Hasleton PS; Yonan NA; Rhaman AN; Deiraniya AK; Campbell CS; Brooks NH; Dyer PA
    Transplantation; 1994 Sep; 58(6):719-22. PubMed ID: 7940693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of steroid withdrawal on the development of lipid abnormalities and obesity in heart transplant recipients.
    Lake KD; Reutzel TJ; Pritzker MR; Jorgensen CR; Emery RW
    J Heart Lung Transplant; 1993; 12(4):580-90. PubMed ID: 8369320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study.
    Ross HJ; Gullestad L; Pak J; Slauson S; Valantine HA; Hunt SA
    J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimum maintenance trough levels of cyclosporine in heart transplant recipients given corticosteroid-free regimen.
    Nohria A; Ehtisham J; Ramahi TM
    J Heart Lung Transplant; 1998 Sep; 17(9):849-53. PubMed ID: 9773855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multi-factor analysis of kidney regraft outcomes.
    Gjertson DW
    Clin Transpl; 2002; ():335-49. PubMed ID: 12971460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-DR matching improves survival after heart transplantation: is it time to change allocation policies?
    Kaczmarek I; Deutsch MA; Rohrer ME; Beiras-Fernandez A; Groetzner J; Daebritz S; Schmoeckel M; Spannagl M; Meiser B; Reichart B
    J Heart Lung Transplant; 2006 Sep; 25(9):1057-62. PubMed ID: 16962466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
    Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypercholesterolemia after heart transplantation: amelioration by corticosteroid-free maintenance immunosuppression.
    Renlund DG; Bristow MR; Crandall BG; Burton NA; Doty DB; Karwande SV; Gay WA; Jones KW; Hegewald MG; Hagan ME
    J Heart Transplant; 1989; 8(3):214-9; discussion 219-20. PubMed ID: 2661771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein abnormalities in long-term stable liver and renal transplanted patients. A comparative study.
    Fernández-Miranda C; de la Calle A; Morales JM; Guijarro C; Aranda JL; Gómez-Sanz R; Gómez-Izquierdo T; Larumbe S; Moreno E; Rodicio JL; del Palacio A
    Clin Transplant; 1998 Apr; 12(2):136-41. PubMed ID: 9575402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy.
    Woodle ES; First MR; Pirsch J; Shihab F; Gaber AO; Van Veldhuisen P;
    Ann Surg; 2008 Oct; 248(4):564-77. PubMed ID: 18936569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac allograft function with corticosteroid-free maintenance immunosuppression.
    O'Connell JB; Bristow MR; Rasmussen LG; Ratkovec RM; Gay WA; Jones KW; Renlund DG
    Circulation; 1990 Nov; 82(5 Suppl):IV318-21. PubMed ID: 2121388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.